# PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood

> **NCT03831256** · NA · ACTIVE_NOT_RECRUITING · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 7849 (actual)

## Conditions studied

- Prenatal Disorder
- Aneuploidy

## Interventions

- **DIAGNOSTIC_TEST:** Traditional integrated prenatal screening
- **DIAGNOSTIC_TEST:** Second-tier Non-invasive prenatal screening (NIPS)
- **DIAGNOSTIC_TEST:** First-tier Non-invasive prenatal screening (NIPS)
- **DIAGNOSTIC_TEST:** Invasive prenatal testing for fetal aneuploidy

## Key facts

- **NCT ID:** NCT03831256
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-13
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 7849 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831256, "PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03831256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*